Multiple large analyses have identified a modest increase in the chance of developing elevated blood sugar or type 2 diabetes among statin users—typically in the 9–13 % relative risk range. Absolute risk remains small for most individuals, but the association is strong enough that major guidelines now recommend periodic glucose monitoring.
People with pre-existing risk factors (overweight, family history, metabolic syndrome) benefit most from keeping an eye on fasting glucose or HbA1c every 6–12 months.
Brain Fog, Memory, and Mood Shifts
Thousands of voluntary reports to drug safety databases describe temporary difficulties with short-term memory, word-finding, or concentration while taking statins. In most documented cases these changes reverse after dose reduction or discontinuation.
Mood irritability or low mood has also been linked in smaller studies, possibly related to cholesterol’s role in producing brain signaling molecules. Not everyone experiences this, but when it occurs it can feel alarming.
